Tmc Life Sciences Berhad operates in the General medical & surgical hospitals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tmc Life Sciences Berhad with three other
health care providers in Asia:
sales of 4.87 billion Indian Rupees [US$65.77 million]
of which 100%
was Hospitals and medical Diagnostics),
Nawaloka Hospitals PLC
of SRI LANKA
(8.56 billion Sri Lanka Rupees [US$46.20 million]
Ceylon Hospitals PLC
based in SRI LANKA
(5.98 billion Sri Lanka Rupees [US$32.27 million]
Tmc Life Sciences Berhad reported sales of 184.09 million Malaysian Ringgits (US$45.23 million)
June of 2020.
decrease of 5.6%
versus 2019, when the company's sales were 194.98 million Malaysian Ringgits.